Sandbox ID Gastrointestinal and Intraabdominal: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
mNo edit summary
Line 1: Line 1:
===Anthrax,  gastrointestinal ===
===Anthrax,  gastrointestinal ===
* '''Gastrointestinal anthrax'''
:* Preferred regimen: [[Ciprofloxacin]] 400 mg intravenously every 8 h {{or}} doxycycline 100 mg intravenously every 12 h combined with second agent: [[clindamycin]] 600 mg intravenously every 8 h or [[penicillin]] G 4 MU every 4–6 h {{or}} [[meropenem]] 1 gm intravenously every 6–8 h or [[rifampin]] 300 mg every 12 h.


===Appendicitis===
===Appendicitis===
Line 26: Line 29:


===Infectious diarrhea===
===Infectious diarrhea===
====Immunocompetent====
:* Shigella species:
::*Preferred regimen:
:::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. for 3 days (if susceptible ) {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], {{or}} 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
:::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. for 3 days
::*Preferred regimen:
:::*Adult dose: [[Nalidixic acid]]  1 g/d X 5 d {{or}} [[ceftriaxone]]; [[azithromycin]]
:::*Pediatric dose:  [[Nalidixic acid]],  55 mg/kg/d
:*Campylobacter species
::*Preferred regimen:
:::*[[Erythromycin]], 500 mg b.i.d. X 5 d
:*Escherichia coli species
::*Enterotoxigenic
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d. for 3 days (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enteropathogenic
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enteroinvasive
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enterohemorrhagic
:::*Preferred regimen:
::::*Avoid antimotility drugs (E-II) [136]; role of antibiotics unclear, and administration should be avoided.
::*Aeromonas/Plesiomonas
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d. for 3 days (if susceptible), [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Yersinia species
:::*Preferred regimen:
::::*Antibiotics are not usually required deferoxamine therapy should be withheld; for severe infections or associated bacteremia treat as for immunocompromised hosts.


===Leptospirosis===
===Leptospirosis===
Line 57: Line 98:
===Whipple's disease===
===Whipple's disease===


===Gastrointestinal anthrax===
{{Details-tx|Anthrax medical therapy}}
* '''Gastrointestinal anthrax'''
:* Preferred regimen: [[Ciprofloxacin]] 400 mg intravenously every 8 h {{or}} doxycycline 100 mg intravenously every 12 h combined with second agent: [[clindamycin]] 600 mg intravenously every 8 h or [[penicillin]] G 4 MU every 4–6 h {{or}} [[meropenem]] 1 gm intravenously every 6–8 h or [[rifampin]] 300 mg every 12 h.


----
----


===Infectious diarrhea===
===Infectious diarrhea===
{{Details-tx|Infectious diarrhea#Treatment}}


* '''Infectious diarrhea'''
* '''Infectious diarrhea'''
====Immunocompetent====
:* Shigella species:
::*Preferred regimen:
:::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. for 3 days (if susceptible ) {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], {{or}} 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
:::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. for 3 days


::*Preferred regimen:
:::*Adult dose: [[Nalidixic acid]]  1 g/d X 5 d {{or}} [[ceftriaxone]]; [[azithromycin]]
:::*Pediatric dose:  [[Nalidixic acid]],  55 mg/kg/d
:*Campylobacter species
::*Preferred regimen:
:::*[[Erythromycin]], 500 mg b.i.d. X 5 d
:*Escherichia coli species
::*Enterotoxigenic
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d. for 3 days (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enteropathogenic
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enteroinvasive
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d.,X 3 d (if susceptible), {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Enterohemorrhagic
:::*Preferred regimen:
::::*Avoid antimotility drugs (E-II) [136]; role of antibiotics unclear, and administration should be avoided.
::*Aeromonas/Plesiomonas
:::*Preferred regimen:
::::*[[TMP-SMZ]], 160 and 800 mg, respectively, b.i.d. for 3 days (if susceptible), [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], or 500 mg [[ciprofloxacin]] b.i.d. for 3 days)
::*Yersinia species
:::*Preferred regimen:
::::*Antibiotics are not usually required deferoxamine therapy should be withheld; for severe infections or associated bacteremia treat as for immunocompromised hosts.
----
----


Revision as of 04:30, 30 May 2015

Anthrax, gastrointestinal

  • Gastrointestinal anthrax
  • Preferred regimen: Ciprofloxacin 400 mg intravenously every 8 h OR doxycycline 100 mg intravenously every 12 h combined with second agent: clindamycin 600 mg intravenously every 8 h or penicillin G 4 MU every 4–6 h OR meropenem 1 gm intravenously every 6–8 h or rifampin 300 mg every 12 h.

Appendicitis

Biliary sepsis

Cholangitis

Cholecystitis

Diverticulitis

Esophagitis

Hepatic abscess

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatitis E

Infectious diarrhea

Immunocompetent

  • Shigella species:
  • Preferred regimen:
  • Preferred regimen:
  • Campylobacter species
  • Preferred regimen:
  • Escherichia coli species
  • Enterotoxigenic
  • Preferred regimen:
  • Enteropathogenic
  • Preferred regimen:
  • Enteroinvasive
  • Preferred regimen:
  • Enterohemorrhagic
  • Preferred regimen:
  • Avoid antimotility drugs (E-II) [136]; role of antibiotics unclear, and administration should be avoided.
  • Aeromonas/Plesiomonas
  • Preferred regimen:
  • Yersinia species
  • Preferred regimen:
  • Antibiotics are not usually required deferoxamine therapy should be withheld; for severe infections or associated bacteremia treat as for immunocompromised hosts.

Leptospirosis

Pancreatitis

Peliosis hepatitis

Peptic ulcer disease

Peritonitis, secondary to bowel perforation

Peritonitis, secondary to dialysis

Peritonitis, secondary to ruptured appendix

Peritonitis, secondary to ruptured diverticula

Peritonitis, spontaneous bacterial

Post-transplant infected biloma

Splenic abscess

Tropical sprue

Typhlitis

Variceal bleeding, prophylaxis

Whipple's disease

Infectious diarrhea

  • Infectious diarrhea

Peptic ulcer disease

Further information: Peptic ulcer medical therapy and therapeutic approach
  • Peptic ulcer disease

Esophagitis

Further information: Esophagitis medical therapy and therapeutic approach
  • Esophagitis

References

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_ID_Gastrointestinal_and_Intraabdominal&oldid=1103528"